Xarelto Bleeding Lawsuit Gets Rolling In Louisiana

Everyone’s seen the commercials urging patients who have taken Xarelto to contact the law firms’ numbers onscreen immediately to join a xarelto bleeding lawsuit. Well, the drug companies are actually countering the wrongful death lawsuits and complaints contending that a third party is supporting the nationwide lawsuits as a witch hunt.

In addition, Bayer and Johnson & Johnson contend that doctors have not prescribed other drugs (namely 50-year-standing and trusted blood thinner Warfarin in its place.)

The first xarelto bleeding lawsuit began in April in New Orleans. This patient experienced severe gastrointestinal bleeding within the first month of taking Xarelto. It landed him in the hospital. There’s no antidote, and doctors had to do a costly and dangerous blood transfusions. He could have bled to death.

This claimant calls out manufacturer negligence because they did not inform doctors or patients that there is no antidote to the drug; meaning its blood thinning properties cannot be reversed once it gets to work. He was fortunate to survive, because his doctors were able to counter Xarelto with a blood transfusion in time.

Hundreds of the 10,000 other Xarelto wrongful death lawsuits time was not on their side. Many of those patients died from exactly that bleeding issue.

The Pharmaceutical Companies Respond

In response, the drug companies came back swinging with responses that seem weak. They claim Xarelto is more effective than Warfarin and is safe. Warfarin has been trusted as the main blood thinner for at least 50 years. In theory should not Warfarin also cause bleeding deaths because it too is a blood thinner?

Actually, Warfarin can cause bleeding out episodes that lead to death, if it is improperly dosed. There’s no money in suing about a long-standing blood thinner, though. If patients take too much Warfarin, they can bleed to death. Though, hospitals use Warfarin all the time without much in the way of dramatic effect other than achieving blood thinning.

The patients could file malpractice lawsuits against doctors. Yet, the question begs, why are the pharmaceutical companies only citing that the doctors did not choose to prescribe something else? Judge Fallon dismissed this argument, and the lawsuits are collectively filed under MDL 2592.

The pharma companies are also counter-claiming that a third-party is funding the xarelto bleeding lawsuit in encouraging people to join the suit. FDA is still backing its approval of Xarelto, but has issued a black box warning for the drug. Black box warnings have been issued on other blood-related pharma products over the years.

Defendants In Xarelto Lawsuit Wants To Know About The Xarelto Lawsuit Funding

The Philadelphia Xarelto mass tort seems to be edging closer to the trial stage, and as this is happening, Bayer AG and Janssen Pharmaceuticals have hinted they want to know who are  third-party lawsuit funding are. There are people providing lawsuit funding against the companies. The defendants want to know who are the people funding the plaintiffs in the Xarleto lawsuits.

Janssen and Bayer filed a motion in April. The motion was requesting the court to compel discovery in regards to third-party lawsuit funding. The motion, filed with the Philadelphia Court of Common Peas, was filed at the beginning of April.

Bellwether cases in the lawsuit have been placed on a shortlist. Defendants now want to know more about third-party ligation funding. They would like to find out more details before the selection of bellwether cases for the trials.

As of now, there are around 1,200 cases on the tort docket. However, 24 cases have qualified for bellwether status. The defendants in the case feel that in order to determine which cases on the shortlist will be tried first, then they should know who is providing the lawsuit funding.

Xarelto arrived on the market as an alternative to Warfarin, which is a well-known blood-thinner that has considered being the gold-standard. Xarelto has been proven to be effective at helping prevent blood clots and stroke in older patients. The downside of Warfarin is that strict dieting is required and there are other factors that are required in order for patients to remain in a safe zone and to avoid bleeding events, as well as serious hemorrhages.

The FDA approved Xarelto as an alternative to Warfarin, and it did not require the same amount of monitoring that Warfarin required. This is one of the reasons why the drug was touted as an effective alternative to Warfarin. It was also touted as an easier and safe alternative to Warfarin.

However, the side effects associated with Xarelto have caused a lot of problems for many people and the drug was brought to the market without an agent to reverse the thinning properties of the drug. With an infusion of Vitamin K, Warfarin can be reversed, but Xarelto doesn’t respond to Vitamin K infusions. This has led to serious issues, such as bleeding complications and there have been some deaths reported.

Plaintiffs allege that the manufacturers of the drug claimed that it didn’t require the same extent of monitoring that is required with Warfarin, but given the lack of an agent to reverse the drug’s effects, it seems that Xarelto does require a lot of monitoring. Plaintiffs also claim that the manufacturers knew that the drug couldn’t be reversed in the same manner as Warfarin, and if they knew this information, then they wouldn’t have taken the drug. Some plaintiffs said they would have consented to Xarelto if they knew.

The request to find out who is funding the plaintiffs’ lawsuits is a new trend, and the defendants said the motion was filed because they need to understand the context of the selection of bellwether cases and it is in the interest of an orderly processed. The defendants also said it may help determine if the individuals or entities have a stake in the outcome of the lawsuit. In other words, part of the reason is because the defendants want to know if any lawsuit funding has something to gain.

Lawyers represented the plaintiffs countered, saying the requests were broad. They said that it reaches into the territory of attorney-client privilege. As of now, it’s not clear if the defendants’ request will be approved or denied.

Xarelto Claims Picked For Trial in 2017

From Orleans, LA comes the news that the first trial against the medication, Xarelto, will be held in early 2017. Others are due to follow. There is a huge portfolio of xarelto claims against the maker, Jannssen Pharmaceuticals Inc., and Bayer, which are still pending. The number of cases is nearly 14,000.

The plaintiffs allege that Xarelto caused blood to thin so much that it caused serious complications to patients. As there was no antidote to the blood thinner’s power, it caused serious harm. The first plaintiff to have his trial states that he was prescribed the medication for atrial fibrillation or Afib in early 2014. One month later he was in the hospital with bleeding so severe he required many blood transfusions.

He claims the makers mislead the public about the medication’s safety. They also failed to indicate the dangers of the drug to the medical community or to the US Food and Drug Administration. They only referenced certain results from clinical trials to get the pill on the market. The issues of the medication were not disclosed.

Xarelto was compared with its rival medication, Warfarin is also known generically as Coumadin. This medication requires routine blood tests and dietary restrictions of the patients who take it. Xarelto came out as being a much easier medication to take with as much safety and effectiveness as Warfarin.

There were tests done on the two and allegations were made against the readings taken of patients by Inratio. It was believed the readings showed patients in a control group taking too much Warfarin thereby casting a better light on the Xarelto. The FDA feels that any variations in the readings done by Inratio were too slight to skew the results for Xarelto. Originally, Xarelto was approved for DVT or deep vein thrombosis.

Eventually, Xarelto was introduced to the market to be a better, easier way of managing Warfarin patients. It seemed to be too ineffective at reducing the risks of DVT or stroke from atrial fibrillation. It helped manage the levels of Warfarin used. Too much of the Warfarin itself risked hemorrhages, and bleeding.

In their xarelto claims, plaintiffs made note of the lack of an antidote available to combat the excess Xarelto bleeding. With Warfarin, patients are taken care of with a vitamin K infusion. The treatment does not work on Xarelto, leaving it to be a risky medication. Plaintiffs further claim that the makers of Xarelto were irresponsible for claiming that Xarelto required no monitoring. Because it did not have a reversing agent, the opposite became true.

Xarelto came on the market with big expectations. In the first year on the market, it brought in close to $600 million. By the end of 2013, it yielded $2 billion. The future of the drug remains to be seen as these xarelto claims lawsuits come to trial.

What Makes Xarelto Different Than The Other Blood Thinners?

What makes Xarelto different than the other blood thinner medication is that it is actually a Xa inhibitor, meaning that it works to think out the blood by blocking thrombin. This is the chemical found in the blood that leads to a blood clot. Being able to block thrombin, Xarelto works to break down and then prevent any blood clot that can be a problem if you have gone through either knee replacement or hip surgery, are going through deep vein thrombosis or have been diagnosed as having atrial fibrillation.

Understanding The Side Effects Blood Thinner Medication Xarelto

The major side effect linked to Xarelto use is internal bleeding that is uncontrollable. Internal bleeding can be a lot more dangerous than external bleeds, as it is more difficult to identify. Since Xarelto will keep the blood from clotting, internal bleeding events can result in the need for hospitalization right away, or even death.

Along with severe internal bleeding, one serious risk that has been linked to the use of Xarelto is that it can lead to blood clotting if the person stops taking the drug before they are supposed to. This is something reported as happening whenever a patient is transitioning from Xarelto because there is no reversal agent, back to the drug Warfarin, which happens to have a reversal agent in it.

Risks Reported By The FDA

Back in 2013, the FDA put out a report that was focused on adverse medical events that are linked to the use of Xarelto. The report noted that about 2,100 of the people surveyed had reported adverse events concerning Xarelto. Out of that, 1,821 of the people cited Xarelto as being the main cause of the event.

The major four side effects to be reported in the study were:

– Deep Vein Thrombosis

– Pulmonary Embolism

– Hemorrhages

– Gastrointestinal Bleeds

Some of the other adverse events that were included are cerebrovascular incidents, thrombosis, edema, dyspnea, and hematoma and hemoglobin deficiency. With 891 of the cases that were reported, hospitalization was necessary. Unfortunately, 183 of the cases resulted in the death of the patient.

Deep Vein Thrombosis & Pulmonary Embolism

A pulmonary embolism is something that happens when the blood flowing to the lungs gets blocked due to a blood clot. This is most commonly caused by a deep vein thrombosis, which is where a blood clot gets formed down in the veins of the legs or arms, then travels into the lungs where it forms a blockage. The symptoms of pulmonary embolism include severe chest pain, coughing up blood, and shortness of breath. The symptoms might only occur after serious damage is already done. A pulmonary embolism is difficult to diagnose, often leading to death.

Gastrointestinal Bleeding

This is internal bleeding in the abdominal area, which can be very serious. The abdominal region holds a lot of vital organs. In the event that there is an internal bleed, the blood can pool around such organs and then cut them off from the supply of blood that is freshly oxygenated. Whenever organs are cut off from oxygen for long, they will start to die. The signs of a gastrointestinal bleed can include coughing up blood or vomiting it up, resembling coffee grounds.

Brain Bleeds

Internal bleeding in the brain has been always very dangerous. This can result in suffocation of the brain cells as they starve for oxygen. If they get cut off from oxygen for far too long, they can begin to die, leading to effects that are similar to a stroke. The signs that there is a brain bleed can include numbness in the arms, legs, or face, speech that is slurred, difficulty when moving or walking, harsh headaches, lack of coordination and impaired vision.

Many critics say that Xarelto is also far more dangerous than other available blood thinner medication because there is nothing that can be used as a reversal agent. If any patient that is taking Xarelto goes through internal bleeding, you do not have a drug that will counteract it to stop the bleeding.

Xarelto Makers Are Claiming Legal Actions For Patent Infringement Cases

The makers of the Xarelto drug have filed a lawsuit for patent infringement cases. Janssen Pharmaceuticals and Bayer A.G. have filed a lawsuit against the company Brecenridge Pharmaceutical, alleging that the company has tried to infringe on the Xarelto patent. Bayer is the maker of the anticoagulant in most countries; also Janssen makes it in the U.S.

Breckenridge has filed an Abbreviated New Drug Application with the FDA, which is for a generic version of the anticoagulant. Both Bayer and Janssen believe that as soon as the application is approved, Breckenridge will release their generic version of the drug. The existing patent for Xarelto, however, will not expire until the end of the year 2020.

The accusations of patent infringement cases were based on reasons, since Boehringer Ingelheim, the makers of Pradaxa, sued Brekenridge when they filed an ANDA for a generic version of Pradaxa two years ago. There are concerns that the company is too eager to enter into the anticoagulant market, and that it is throwing patent rights out of the window because of its enthusiasm.

Xarelto and Pradaxa are both big moneymakers, but there are a lot of problems with the drugs. There are lawsuits plaguing both of the medications, and concerns that Pradaxa could have some serious side-effects. Patients who experience uncontrolled bleeding, however, say that Boehringer Ingelheim did not give them sufficient warning of the risks. The company was ordered to pay out $650 million as settlements for lawsuits because of these side effects.

Xarelto is the subject of similar patent infringement cases, with Bayer and Janssen likely facing significant financial penalties because of the 6,000 lawsuits against it – which may be worse because there is no antidote, and the bleeding events can be life-threatening.

The generic version of the drug could escape some of the legal liabilities, since the makers of generics are not required to update their warnings when brand-name drugs change their warnings. They have the choice about whether or not they need to update their packaging to reflect changes.

The generic makers have limited liability because of the restrictions on them. For consumers, this means that they do not have so many rights to hold the generic makers responsible for their drugs. Janssen and Bayer, however, are not eager to hand over the rights to the drugs.

Xarelto Side Effect Concerns

The FDA reports that there were more than 10,600 reports relating to adverse events after taking Xarelto in 2015, and that included 1,121 deaths and 4,508 injuries severe enough to require emergency treatment or hospitalisation. Xarelto is one of the poorest ranked drugs in terms of requiring hospitalization.

Xarelto is used in a lot of different scenarios, and the number of patent infringement cases is growing and growing. There will be a trial in March 2017, and it is expected that by then there could be more than 10,000 outstanding Xarelto lawsuits. Plaintiffs say that the makers misrepresented the drug. The initial approval was controversial. The manufacturers will, naturally, want to avoid a scenario of a third party getting approval for a less-risky generic version.

side effects of anticoagulants

Understanding The Side Effects of Anticoagulants And Xarelto Bleeding Symptoms

Our lawyers are currently accepting various potential lawsuits for individuals that have been injured by the side effects of anticoagulants like Xarelto, known by the generic name Rivaroxaban. This is a widely prescribed anticoagulant drug. Due to recent studies from the Institute for Safe Medication Practices, this drug has been associated with serious or disabling injuries or fatal injuries, to include events such as uncontrollable side effects of anticoagulants such as internal bleeding symptoms and blood clots.

If you have been injured because of Xarelto, you can contact our law firm immediately to get your free confidential lawsuit evaluation. You could be entitled to compensation after filing a lawsuit against the manufacturers. Our lawyers will be happy to help!

What Are The Symptoms?

When there is internal bleeding, this is blood loss that takes place within the patient’s body. Due to the fact that this happens inside, instead of outside the body, the internal bleeds may go unnoticed for periods of time. When the bleeding is rapid, blood could accumulate and start pressing on your internal structures, forming a discolored spot or bulge under the skin. Any severe internal bleeding can lead to loss of consciousness, shock or death.

Xarelto Bleeding Symptoms One Of The Side Effects of Anticoagulants:

– Severe/uncontrollable bleeding

– Long lasting or unexpected bleeding

– Urine that is pink or brown

– Stool that is red or black

– Bruises that have an unknown cause

– Coughing up blood or blood clots

– Vomit that has blood in it or has a coffee ground consistency

– Swelling, joint pain, dizziness, or weakness

Why Is There A Problem With Xarelto?

Back in 2011, Xarelto got approved for treating pulmonary embolism, stroke, deep vein thrombosis and blood clots in patients who had undergone knee or hip replacement surgery. Just like other side effects of anticoagulants, Xarelto comes with a risk of xarelto bleeding symptoms as a side effect. However, the events of internal bleeding with Xarelto are often uncontrollable or cannot be reversed. This makes it a much more dangerous drug than other traditional blood thinners that are available, such as warfarin. Warfarin is a common anticoagulant that has been used for well over 50 years in the United States.

Allegations In Xarelto Lawsuit

With the lawsuits that have been filed against the makers of Xarelto, the claims include the side effects of anticoagulants:

– Failure to warn of internal bleeding events that are unable to be controlled or reversed, as they could be with other blood thinners such as warfarin

– Failure to warn about the uncontrollable internal bleeding

– That there was a defective design

– Failure to properly update the warning labels on the drug in a timely fashion

Some of the former Xarelto users are alleging that Bayer AG and Johnson & Johnson should have made sure to recall the drug once they became aware of the risks.

Do I Have A Lawsuit?

At our law firm, we have a product liability and defective drug litigation group that has experience with cases allowing us to focus on representing patients in Xarelto lawsuits. We are working on handing a number of individual litigations across the nation and investigating potential settlements throughout the 50 states.

If you or someone you love has been injured due to Xarelto and has side effects of anticoagulants, you can contact our firm immediately for a free, confidential case evaluation. You could be entitled to compensation simply by filing a class action suit. We are here to help you!

Texas Woman Files Lawsuit Against Xarelto Alleging Drug Caused Signs Of Internal Bleeding

A Texas woman has filed a lawsuit in the federal court of the Eastern District of New York against the makers of Xarelto, a new class of blood thinner. In it, she alleges that she sustained serious injuries, signs of internal bleeding due to the company’s failure to warn her about the potential risks of using the drug and that the company failed to conduct safety testing that was sufficient before placing the blood thinner on the market. Her lawsuit is similar to many others filed against Janssen and Bayer AG. The case is listed under the federal court docket number 1:14-CV-04524 and is available in its entirety to read below.

December 7, 2015 – BloodThinnerHelp.com reports that a Texas woman has filed a lawsuit in the Eastern District of New York alleging that Janssen Pharmaceuticals and Bayer AG, the manufacturers of Xarelto, failed to provide sufficient warnings to consumers about the potential risk of the signs of internal bleeding with this blood thinner. In federal court, the latest complaint was filed under 1:14-CV-04524.

The lawsuit contains details about how the drug was prescribed to treat a condition known as atrial fibrillation. This condition can cause strokes due to blood clots. As a preventative measure, cases of this type are commonly treated with blood thinners. However, just five months after taking the blood thinner, she experienced an internal bleed that was life threatening. While the complaint does not specify much of the details of the injury, it does state that specialized care will be required due to long tern health effects that occurred as a consequence of the bleed.

After the U.S. Food and Drug Administration approved Xarelto in 2011, it was released to the market for prescription. Initially, the new drug was regarded as an option that was revolutionary, because it did not require a special diet, adjustments by physicians, or regular monitoring. However, once consumers realized that there was no antidote, this early excitement was short lived. Currently, it is seen by many to be the market’s most dangerous blood thinner.

Because there is no antidote, if a patient taking Xarelto begins to show the signs of internal bleeding after an injury, there is no way to get the blood to clot by countering the effects of the drug. In order to keep the patient alive when this happens, blood transfusions and other extreme measures to save their life must be used. In addition, operations are sometimes necessary when pools of blood develop in the spine or brain in order to relieve the built up pressure in the body by draining the blood.

Vitamin K provides an antidote for traditional blood thinners. Because of this, the effects of the traditional blood thinner are counteracted and blood clots can form when an injury occurs. It is the difference between living and dying in these cases.

Federally, there have been about 2,000 cases filed against Xarelto for bleeding that cannot be controlled. In the Eastern District of Louisiana, the Honorable Judge Eldon Fallon is overseeing the consolidation of these cases in Multidistrict litigation number 2To 592. Attorney Joseph Osborne is working to make sure that everyone has the opportunity to evaluate their legal rights if they were affected by Xarelto as these cases are prepared for trial. There may be a significant compensation for individuals who suffered adverse health effects and any signs of internal bleeding due to using Xarelto. To those involved, free legal consultations are available from attorney Osborne.

Please contact our attorney today for additional information or to ask questions about the Xarelto bleeding lawsuits.

Liver Damage Symptoms: Xarelto Causes Another Life Threatening Problem

Xarelo is a new Novel Oral Anticoagulant category (NOAC) blood-thinner medication manufactured by Johnson & Johnson and Bayer AG. It is used for treating several different conditions, including deep vein thrombosis, pulmonary embolism and atrial fibrillation. However, Xarelto is considered to be a high-risk medication and ruled responsible for serious injuries like liver damage symptoms and the deaths of several patients. Hundreds of lawsuits have been filed against the manufacturers of the drug as a result of so many individuals suffering uncontrollable internal bleeding to the point that even after being hospitalized doctors still had no way of stopping it. Unlike other similar drugs like Warfarin, there is no known antidote for reversing the effects of Xarelto, so once life-threatening bleeding takes place; the patient is at risk of death or severe injuries.

However, there are also several other potentially very serious or fatal side effects for Xarelto that are still under post-marketing investigation currently since the drug was introduced in 2008 to the worldwide market. Risk of liver damage is one of the more alarming adverse reactions that is associated with the drug Xarelto. Liver damage symptoms caused by Xarelto have been investigated for being a potential risk for individuals taking Xarelto medication. There have also been several Xarelto-induced liver injury cases that have been reported. These include several cases of acute liver failure. The results from three big international pharmacovigilance databases were recently analyzed. The analysis revealed that Xarelto was suspected to be a cause in a large number of hepatic adverse cases.

Can your liver be damaged by Xarelto?

In addition to gastrointestinal bleeding and internal hemorrhage, liver damage symptoms are the most reported Xarelto side effect. It can be discovered in blood tests by elevated enzymes AST and ALT. The 4 Record study results showed that of the 6,183 patients that were treated with rivaroxaban, 2.33% had increased liver enzyme (transaminase) levels that were over 3 times higher than ULN (upper limit of normal). There were two other cases where patient showed liver damage symptoms after being treated with Xarelto which were published recently in the Journal of American Medical Association, which further confirms this drug’s alarming potential hepatotoxicity.

Another thing that should be noted is that more than two-thirds of the drug, which is administered orally, is eliminated via urine or bile following hepatic metabolism. If liver function has been comprised, the blood levels of the drug may potentially increase due to the liver being unable to eliminate a sufficient quantity of Xarelto out of the body. However, this medication’s main selling points were the fact that blood monitoring was not required and its purported safety. These points were advertised widely over the internet and television.

Without any blood monitoring, it results in patient not being aware if the effects from the drug have increased to the level of growing potentially dangerous due to an increased risk for bleeding accidents. Therefore, this requires that an appropriate adjustment to the dosage be made.

Since being treated with Xarelto can potentially be associated with symptomatic and severe liver damage symptoms and consequently bleeding risk, the physician and patient both need to be fully informed about this potentially significant danger. The drug label should include a warning about the potential symptomatic liver damage; otherwise patients who suffer liver injury as a Xarelto side effect have the right to file a lawsuit in reference to misleading information being provided by the manufacturers.

internal bleeding signs

News About The Latest Xarelto Internal Bleeding Signs

There are a number of side effects associated, and one of the most dangerous is internal bleeding signs, which can lead to death. People have filed lawsuits against Bayer as a result of internal bleeding. They filed lawsuits claiming Bayer did not warn of internal bleeding.

Bayer Healthcare, as well as Johnson & Johnson’s Janssen subsidiary has been hit with a number of product liability lawsuits. The lawsuits have been filed on behalf of people from all around the country. These people have suffered from internal bleeding signs and severe bleeding injuries as a result of Xarelto.

The date for the trials have been set, and the truth is that litigation against Xarelto just keeps on growing because new lawsuits are filed daily, and one of the most recent ones come from a woman in Florida. She claims the medicine caused her husband to die because it leads to fatal internal bleeding signs. The litigation is still in the stages of pretrial, and the dates have already been pushed a number of times, but this time around there are dates for the first two trials, with one being on February 6, 2017 and the other being on March 13, 2017.

The third trial is going to be held in Mississippi on April 24, 2017, and it will also be held on May 30, 2017 in the state of Texas and only these four cases will be heard during the bellwether trials and this is because of the number of lawsuits that have been filed. You may be wondering why these four cases have been chosen and there is a reason for this. The lawsuits were chosen because they are considered to be the most representative cases.

In Xarelto MDL, the defendants will be the manufacturers of Xarelto, which is Janssen Pharmaceuticals, and Bayer AG, and the plaintiffs are accusing the companies of negligence because they are accused of not properly warning people about the dangers of the medicine. The medicine’s side effects don’t include internal bleeding signs episodes that may lead to a person dying and there is nothing on the market that can reverse the medicine’s side effects, and the plaintiffs are accusing the companies of knowing this, yet they still chose to market the medicine and advertise it as a safer drug to use then their competitors’ drugs.

In December 2014 was when MDL was consolidated and since then, there have been a number of lawsuits filed and some of the damages include pain and suffering, as well as loss of wages, medical treatment and even funeral costs. If you have ever taken the medicine or someone you know has, and you or they have experienced internal bleeding signs, then you should speak with an advocate as soon as possible, as they will be able to answer some questions for you. Keep in mind the amount of money you can recover via a lawsuit does depend on a number of factors, such as age, the extent of the injury and whether or not the person died and whether or not the patient had any dependents.

side effects of xarelto

The Truth About The Blood Thinner And The Side Effects Of Xarelto

Have you taken Xarelto and now you are wondering if you have suffered any side effects from it? Maybe you are wondering what the side effects of Xarelto are. If you are curious about the side effects of xarelto, then continue to read the rest of this article, as some of the side effects will be discussed below.

1. Common Side Effects of Xarelto-

There are quite a few common side effects associated with Xarelto, and this includes pain in the back, bleeding gums, as well as blood in your stool. The pain in your back could vary in pain, and so can the amount of blood in your stool. Asides from those three side effects, other common ones include bowel or bladder dysfunction, as well as tingling feelings or the feeling of pins and needles. You might also experience some itching or burning.

Those who cough off blood or have a hard time breathing or swallowing may be doing so because of using Xarelto. The drug can also cause you to have a headache and you might feel dizzy, as this is another side effect associated with the drug. Another common side effect that some users may experience is weakness in one or both of their legs.

Nosebleeds, prolonged bleeding from cuts and numbness are other common side effects associated with Xarelto. Not only that, but other common ones include stools that are tarry and are red or black. If your urine is red or dark brown, then it may be because you are using Xarelto, and if you are a woman, then you may experience an increased menstrual flow.

There are even more common side effects that the drug has. One of the most serious and common ones is throwing up blood. Sometimes you might vomit material that resembles coffee grounds, and you might experience paralysis.

visual.ly Image

2. Less Common Side Effects-

Xarelto can cause less common side effects, which includes fainting. Not everyone will experience this side effect, but some people may. Feeling pain in your arms or legs, as well as wound secretion are other less common side effects of xarelto.

3. Rare Side Effects-

Asides from the common and less common side effects, there are a few rare ones that some users may encounter. One of the most rarest ones is burning while urinating. As for how much it will burn, that depends, but generally speaking, a burning sensation may be felt by some users of Xarelto

Another rare one is having a very hard time urinating. You may feel like you have to urinate, but you may find it difficult to do. Asides from being difficult, you might even find it painful to urinate.

If you experience those side effects, and you are taking Xarelto, then you should contact your doctor. The side effects may be the result of using the drug. Even if they are not, it is still a good idea to have a doctor look at you.

4. Unknown Side Effects-

There are some side effects of xarelto which are not really familiar, therefore it is not really proven that some unknown incidents are a result of using Xarelto. With that said, it is possible that some other side effects associated with Xarelto are pain in the stomach region, as well as swelling and your vision may become blurred or your skin could blister up or peel. Very dark urine is another potential side effect, but unproven one.

There are two more side effects that could potentially be linked to Xarelto and this includes blisters. If you take the drug and notice that blisters have appeared, then this may very well be because of Xarelto. Muscle spasms may also be experienced by Xarelto users, and if you do experience such symptoms, then you might want to consider getting medical attention because it may or may not be the results of using Xarelto.

As you can see, there are a lot of different side effects of Xarelto. If you suspect that you have suffered from any of the above side effects, then you should visit your doctor as soon as possible. They will be able to examine you, speak with you and determine whether or not Xarelto resulted in side effects.